首页> 美国卫生研究院文献>Disease Markers >14-3-3 Sigma And p53 Expression in Gastric Cancer and Its Clinical Applications
【2h】

14-3-3 Sigma And p53 Expression in Gastric Cancer and Its Clinical Applications

机译:14-3-3 Sigma和p53在胃癌中的表达及其临床应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

14-3-3 sigma (σ) induces G2 arrest enabling the repair of damaged DNA. The function of 14-3-3 σ is frequently lost in tumor cells, indicating a potential tumor suppressor function. The purpose of this study was to evaluate the prognostic value of 14-3-3 σ expression in human gastric cancer. 14-3-3 σ expression was analyzed by immunohistochemistry in 157 tumor samples of patients, who underwent resection for gastric cancer. Since 14-3-3 σ is involved in the p53 network, p53 expression was detected in parallel and correlated with 14-3-3 σ. 14-3-3 σ was found to be overexpressed in 75 (47.8%) of 157 cases, the overexpression rate of p53 protein was 27.4%. 14-3-3 σ overexpression was statistically significantly associated with pT-stage (p=0.041) pN-stage (p=0.015) and UICC-stage (p=0.019) and showed a borderline significance with Lauren classification (p=0.057). Univariate survival calculations revealed a coexistent 14-3-3 σ and p53 overexpression as a significant predictor of disease-free survival. Multivariate analysis did not unfold 14-3-3 as an independent prognostic factor for disease-free survival and overall survival. Concomitant 14-3-3 σ and p53 overexpression in tumor cells of patients with gastric cancer identifies a population of patients with relatively unfavorable prognosis.
机译:14-3-3 sigma(σ)诱导G2阻滞,从而修复受损的DNA。 14-3-3σ的功能在肿瘤细胞中经常丢失,表明潜在的抑癌功能。这项研究的目的是评估14-3-3σ表达在人胃癌中的预后价值。通过免疫组织化学分析了157例接受胃癌切除的患者肿瘤样品中14-3-3σ的表达。由于p53网络涉及14-3-3σ,因此并行检测到p53表达并与14-3-3σ相关。 157例中的75例(47.8%)发现14-3-3σ过表达,p53蛋白过表达率为27.4%。 14-3-3σ过表达与pT阶段(p = 0.041),pN阶段(p = 0.015)和UICC阶段(p = 0.019)在统计学上显着相关,并且在Lauren分类中具有临界意义(p = 0.057) 。单变量生存期计算表明14-3-3σ和p53共存是无病生存期的重要预测指标。多变量分析并未将14-3-3作为无病生存和总体生存的独立预后因素。胃癌患者肿瘤细胞中伴随的14-3-3σ和p53过表达确定了预后相对较差的患者群体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号